» Articles » PMID: 27899087

Paradoxical Physiological Responses to Propranolol in a Rett Syndrome Patient: a Case Report

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2016 Dec 1
PMID 27899087
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rett Syndrome (RTT), caused by a loss-of-function in the epigenetic modulator: X-linked methyl-CpG binding protein 2 (MeCP2), is a pervasive neurological disorder characterized by compromised brain functions, anxiety, severe mental retardation, language and learning disabilities, repetitive stereotyped hand movements and developmental regression. An imbalance in the sympathetic and the parasympathetic nervous system (dysautonomia) and the resulting autonomic storms is a frequent occurrence in patients with RTT. The prototypical beta blocker propranolol has been used to manage sympathetic hyperactivity in patients with RTT.

Case Presentation: A 13 year old girl with RTT was referred to the Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD), South London and Maudsley NHS Foundation Trust. Her clinical picture included disordered breathing with concomitant hyperventilation and apnoea, epilepsy, scoliosis, no QT prolongation (QT/QTc [372/467 ms on automated electrocardiogram [ECG], but manually calculated to be 440 ms]), no cardiac abnormalities (PR interval: 104 ms, QRS duration: 78 ms), and generalised anxiety disorder (ICD-10-CM Diagnosis Code F41.1). She was also constipated and was fed via percutaneous endoscopic gastrostomy (PEG). To manage the dysautonomia, propranolol was given (5 mg and 10 mg) and in parallel her physiological parameters, including heart rate, skin temperature and skin transpiration, were monitored continuously for 24 h as she went about her activities of daily living. Whilst her skin temperature increased and skin transpiration decreased, unexpectedly there was a significant paradoxical increase in the patient's average heart rate following propranolol treatment.

Conclusion: Here, we present a unique case of a paradoxical increase in heart rate response following propranolol treatment for managing dysautonomia in a child with RTT. Further studies are warranted to better understand the underlying dysautonomia in patients with RTT and the impact this might have on treatment strategies in rare disorders such as RTT.

Citing Articles

Acute Cardiovascular and Cardiorespiratory Effects of JWH-018 in Awake and Freely Moving Mice: Mechanism of Action and Possible Antidotal Interventions?.

Marchetti B, Bilel S, Tirri M, Corli G, Roda E, Locatelli C Int J Mol Sci. 2023; 24(8).

PMID: 37108687 PMC: 10142259. DOI: 10.3390/ijms24087515.


Autonomic Characteristics of Sudden Unexpected Death in Epilepsy in Children-A Systematic Review of Studies and Their Relevance to the Management of Epilepsy in Rett Syndrome.

Singh J, Lanzarini E, Santosh P Front Neurol. 2021; 11:632510.

PMID: 33613425 PMC: 7892970. DOI: 10.3389/fneur.2020.632510.


Differentiating Females with Rett Syndrome and Those with Multi-Comorbid Autism Spectrum Disorder Using Physiological Biomarkers: A Novel Approach.

Iakovidou N, Lanzarini E, Singh J, Fiori F, Santosh P J Clin Med. 2020; 9(9).

PMID: 32887357 PMC: 7563706. DOI: 10.3390/jcm9092842.


Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade.

Rodrigues W, Miguel C, Lazo-Chica J, Trindade da Silva C, Vieira C, Clemente-Napimoga J J Indian Soc Periodontol. 2019; 23(6):511-516.

PMID: 31849395 PMC: 6906902. DOI: 10.4103/jisp.jisp_77_19.


Autonomic dysfunction and sudden death in patients with Rett syndrome: a systematic review.

Singh J, Lanzarini E, Santosh P J Psychiatry Neurosci. 2019; 45(3):150-181.

PMID: 31702122 PMC: 7828978. DOI: 10.1503/jpn.190033.


References
1.
Chen L, Chen K, Lavery L, Baker S, Shaw C, Li W . MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Proc Natl Acad Sci U S A. 2015; 112(17):5509-14. PMC: 4418849. DOI: 10.1073/pnas.1505909112. View

2.
Tai D, Liu Y, Hsu W, Ma Y, Cheng S, Liu S . MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome. Nat Commun. 2016; 7:10552. PMC: 4743023. DOI: 10.1038/ncomms10552. View

3.
Theoharides T, Athanassiou M, Panagiotidou S, Doyle R . Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. J Neuroimmunol. 2015; 279:33-8. DOI: 10.1016/j.jneuroim.2014.12.003. View

4.
Ming X, Patel R, Kang V, Chokroverty S, Julu P . Respiratory and autonomic dysfunction in children with autism spectrum disorders. Brain Dev. 2015; 38(2):225-32. DOI: 10.1016/j.braindev.2015.07.003. View

5.
Herrera J, Ward C, Pitcher M, Percy A, Skinner S, Kaufmann W . Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs. Dis Model Mech. 2015; 8(4):363-71. PMC: 4381335. DOI: 10.1242/dmm.020131. View